With our cutting-edge treatments, you can finally enjoy a life free of obesity-related worries and complications
Does GLP-1 cause hypoglycemia
Now that weve shown that hormone-based therapies can be so effective, I think its changed the worlds perspective that its not a losing battle to treat obesity. Daniel Drucker, professor of medicine at the University of Toronto, who codiscovered GLP-1 in the 1980s, says more drugs are needed because theres no telling how long the current shortage of Wegovy and Zepbound will last
So these compounded pharmacies do fill an important need
In a statement to CBS News Detroit, the company said it is ending coverage of GLP-1 drugs "for large group fully insured members beginning January 1, 2025, or on a group's 2025 health coverage renewal date." Additionally, the company said it will change prior authorization requirements for Saxenda, Wegovy and Zepbound beginning Aug
The expansion of Medicaid could address some of these factors